We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current FAB market cap is 2.23M. The company's latest EPS is GBP -0.0437 and P/E is -0.86.
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 2.18M | 3.9M | 4.17M | 4.8M | 2.9M |
| Operating Income | -777k | -1.06M | -1.19M | -1.35M | -2.89M |
| Net Income | -1.26M | -697k | -2.9M | -1.2M | -2.6M |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 6.24M | 6.04M | 5.83M | 4.92M | 2.06M |
| Total Liabilities | 889k | 1.23M | 1.08M | 1.23M | 939k |
| Total Equity | 5.35M | 4.81M | 4.75M | 3.68M | 1.12M |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -1.1M | -160k | -1.14M | -325k | -1.75M |
| Investing | -1.38M | -103k | -362k | -257k | -111k |
| Financing | -28k | -184k | 2.65M | -55k | 3k |
| Market Cap | 2.23M |
| Price to Earnings Ratio | -0.86 |
| Price to Sales Ratio | 0.77 |
| Price to Cash Ratio | 11.36 |
| Price to Book Ratio | 1.99 |
| Dividend Yield | - |
| Shares Outstanding | 59.45M |
| Average Volume (1 week) | 1.38M |
| Average Volume (1 Month) | 1.43M |
| 52 Week Change | -90.26% |
| 52 Week High | 50.00 |
| 52 Week Low | 3.10 |
| Spread (Intraday) | 0.1 (2.63%) |
| Company Name | Fusion Antibodies Plc |
| Address |
c/o tughans solicitors belfast BT1 3GG |
| Website | https://www.fusionantibodies.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
